Hexagon Nutrition Completes Commercial Process Validation for VIT A+
Hexagon Nutrition Ltd 路 Others (Uncategorized) 路 30 Sept 2026, 12:03 am
Hexagon Nutrition Completes Commercial Process Validation for VIT A+ Hexagon Nutrition and Particles for Humanity have successfully completed commercial-scale process validation for PFH-VAP, a stable Vitamin A Palmitate formulation. Announced on 29th Sep'26, the milestone establishes manufacturing feasibility at scale for large-scale food fortification applications. The product will be commercially marketed in international markets under the brand name "VIT A+." The company is currently taking requisite steps toward regulatory compliance and full commercialization.
Original exchange filing (PDF)
More announcements from Hexagon Nutrition Ltd
- Intimation of Audio Recording of Earnings Conference Call for Q2 & H1 FY27 路 17 Nov 2026
- Hexagon Nutrition Limited has informed the Exchange about Investor presentation 路 17 Nov 2026
- Earnings Release for the Financial results for the quarter and half year ended September 30, 2026 路 16 Nov 2026
- Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half yearly ended September 2026. 路 14 Nov 2026
- Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2026, and took on record the Limited review report .... 路 14 Nov 2026
- Hexagon Nutrition Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Hexagon Nutrition Limited has informed the Exchange about Schedule of Meet 路 09 Nov 2026
- Hexagon Nutrition Limited has informed the Exchange about Schedule of Meet. 路 18 Nov 2026
